Exact Mass: 456.00000220000004

Exact Mass Matches: 456.00000220000004

Found 27 metabolites which its exact mass value is equals to given mass value 456.00000220000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

6-(Dibromomethylene)testosterone

6-(Dibromomethylene)-17beta-hydroxyandrost-4-en-3-one; 6-(Dibromomethylene)testosterone

C20H26Br2O2 (456.02994160000003)


   

Delnatex

DIOXATHION

C12H26O6P2S4 (456.00874359999995)


   

Dihydro-dids

5-isothiocyanato-2-[2-(4-isothiocyanato-2-sulfophenyl)ethyl]benzene-1-sulfonic acid

C16H12N2O6S4 (455.9578212)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

   

Selumetinib

5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboximidic acid

C17H15BrClFN4O3 (456.00000220000004)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.

   

Epicoccin F

Epicoccin F

C18H20N2O6S3 (456.04834600000004)


   

ZINC2144474

ZINC2144474

C20H10F6N2S2 (456.0189572)


   

xestonariene B

xestonariene B

C19H22Br2O3 (455.99355819999994)


   

xestonariene D

xestonariene D

C19H22Br2O3 (455.99355819999994)


   

xestonariene E

xestonariene E

C19H22Br2O3 (455.99355819999994)


   

zinc ethylphenyldithiocarbamate

zinc ethylphenyldithiocarbamate

C18H20N2S4Zn (455.980073)


   

Methyl 3-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-4-carboxylate

Methyl 3-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-4-carboxylate

C16H13IN2O4S (455.96407680000004)


   

hexamethonium iodide

hexamethonium iodide

C12H30I2N2 (456.04983999999996)


   

zinc bis(acetato-O)dioxouranate

zinc bis(acetato-O)dioxouranate

C4H10O6UZn (456.027667)


   

(2,4-Dichlorobenzyl)triphenylphosphonium Chloride

(2,4-Dichlorobenzyl)triphenylphosphonium Chloride

C25H20Cl3P (456.03681400000005)


   

2,6-dichlorobenzyl triphenylphosphonium chloride

2,6-dichlorobenzyl triphenylphosphonium chloride

C25H20Cl3P (456.03681400000005)


   

3,3,5,5-tetrakis(trifluoromethyl)benzhydrol

3,3,5,5-tetrakis(trifluoromethyl)benzhydrol

C17H8F12O (456.03835019999997)


   

Vinyltriethylsilane(hexafluoroacetylacetonate)silver(I)

Vinyltriethylsilane(hexafluoroacetylacetonate)silver(I)

C13H19AgF6O2Si (456.0109396)


   

Dipicryl sulfide

Dipicryl sulfide

C12H4N6O12S (455.96079440000005)


   

BIS((1,5-CYCLOOCTADIENE)(HYDROXO)RHODIUM)

BIS((1,5-CYCLOOCTADIENE)(HYDROXO)RHODIUM)

C16H26O2Rh2++ (456.0042756)


   

Gdc-0623

Gdc-0623

C16H14FIN4O3 (456.0094656)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Thiamine thiothiazolone pyrophosphate

Thiamine thiothiazolone pyrophosphate

C12H18N4O7P2S2 (456.0092138)


   

Selumetinib

Selumetinib (AZD6244)

C17H15BrClFN4O3 (456.00000220000004)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.

   

8-Oxo-guanosine diphosphate

8-Oxo-guanosine diphosphate

C10H12N5O12P2-3 (455.9957712)


   

3-chloro-N-[3-(furan-2-ylmethylcarbamoyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl]-1-benzothiophene-2-carboxamide

3-chloro-N-[3-(furan-2-ylmethylcarbamoyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl]-1-benzothiophene-2-carboxamide

C22H17ClN2O3S2 (456.0369082)


   

7-Methyl-7,8-dihydroguanosine-5-diphosphate(3-)

7-Methyl-7,8-dihydroguanosine-5-diphosphate(3-)

C11H16N5O11P2-3 (456.03215459999996)


   

7-Hydroxy-8-[(naphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonate

7-Hydroxy-8-[(naphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonate

C20H12N2O7S2-2 (456.0085922)


   

7-Methyl-7,8-dihydroguanosine-5-diphosphate(3-)

7-Methyl-7,8-dihydroguanosine-5-diphosphate(3-)

C11H16N5O11P2 (456.03215459999996)


An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of 7-methyl-7,8-dihydroguanosine-5-diphosphate.